Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23426)

• Formulation Name: Disopyramide Phosphate eq 150mg base capsule
• Company: Pfizer Laboratories Div Pfizer

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Disopyramide	(DM5SYZP)	Long QT syndrome	BC65.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Erythrosine sodium anhydrous	(E00324)	27872	Colorant
Food blue 1 aluminum lake	(E00512)	11979396	Colorant
Gelatin	(E00630)	Not Available	Other agent
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant
Sunset yellow FCF	(E00255)	17730	Colorant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent